Page 16 of 18 SEC Filing EXHIBIT A JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of Ocera Therapeutics, Inc. and further agree that this agreement be included as an exhibit to such filing. Each party to the agreement expressly authorizes each other party to file on its behalf any and all amendments to such statement. Each party to this agreement agrees that this joint filing agreement may be signed in counterparts. In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 3rd day of March, 2016. Venrock Healthcare Capital Partners, L.P. VHCP Co-Investment Holdings, LLC By: VHCP Management, LLC, By: VHCP Management, LLC, its General Partner its Manager By: /s/ David L. Stepp By: /s/ David L. Stepp Name: David L. Stepp Name: David L. Stepp Title: Authorized Signatory Title: Authorized Signatory VHCP Management, LLC By: /s/ David L. Stepp Name: David L. Stepp Title: Authorized Signatory /s/ David L. Stepp, as attorney-in-fact Anders Hove /s/ David L. Stepp, as attorney-in-fact Bong Koh Venrock Healthcare Capital Partners II, L.P. VHCP Co-Investment Holdings II, LLC By: VHCP Management II, LLC, By: VHCP Management II, LLC, its General Partner its Manager By: /s/ David L. Stepp By: /s/ David L. Stepp Name: David L. Stepp Name: David L. Stepp Title: Authorized Signatory Title: Authorized Signatory VHCP Management II, LLC By: /s/ David L. Stepp Name: David L. Stepp Title: Authorized Signatory
Follow Ocera Therapeutics Inc. (NASDAQ:OCRX)
Follow Ocera Therapeutics Inc. (NASDAQ:OCRX)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
EXHIBIT A
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of Ocera Therapeutics, Inc. and further agree that this agreement be included as an exhibit to such filing. Each party to the agreement expressly authorizes each other party to file on its behalf any and all amendments to such statement. Each party to this agreement agrees that this joint filing agreement may be signed in counterparts.
In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 3rd day of March, 2016.
| Venrock Healthcare Capital Partners, L.P. | VHCP Co-Investment Holdings, LLC | |||||||||||
| By: | VHCP Management, LLC, | By: | VHCP Management, LLC, | |||||||||
| its General Partner | its Manager | |||||||||||
| By: | /s/ David L. Stepp | By: | /s/ David L. Stepp | |||||||||
| Name: | David L. Stepp | Name: | David L. Stepp | |||||||||
| Title: | Authorized Signatory | Title: | Authorized Signatory | |||||||||
| VHCP Management, LLC | ||||||||||||
| By: | /s/ David L. Stepp | |||||||||||
| Name: | David L. Stepp | |||||||||||
| Title: | Authorized Signatory | |||||||||||
| /s/ David L. Stepp, as attorney-in-fact | ||||||||||||
| Anders Hove | ||||||||||||
| /s/ David L. Stepp, as attorney-in-fact | ||||||||||||
| Bong Koh | ||||||||||||
| Venrock Healthcare Capital Partners II, L.P. | VHCP Co-Investment Holdings II, LLC | |||||||||||
| By: | VHCP Management II, LLC, | By: | VHCP Management II, LLC, | |||||||||
| its General Partner | its Manager | |||||||||||
| By: | /s/ David L. Stepp | By: | /s/ David L. Stepp | |||||||||
| Name: | David L. Stepp | Name: | David L. Stepp | |||||||||
| Title: | Authorized Signatory | Title: | Authorized Signatory | |||||||||
| VHCP Management II, LLC | ||||||||||||
| By: | /s/ David L. Stepp | |||||||||||
| Name: | David L. Stepp | |||||||||||
| Title: | Authorized Signatory | |||||||||||
Follow Ocera Therapeutics Inc. (NASDAQ:OCRX)
Follow Ocera Therapeutics Inc. (NASDAQ:OCRX)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
